Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.MAPS furthers its mission by: Developing psychedelics and marijuana into prescription medicines; Training therapists and working to establish a network of treatment centers; Supporting scientific research into spirituality, creativity, and neuroscience; and educating the public honestly about the risks and benefits of psychedelics and marijuana.

Updated 2015-12-13. The Crazymeds Manifesto. We help you find the treatment options that suck less.

We need research to understand how depression and related illnesses develop and progress, how and why depression can affect different people in different ways, how to help people feel better, and how to keep symptoms from returning. Without the involvement of individual participants, however, research and medicine would not advance – we need people to make progress. In fact, all of the treatments that modern healthcare offers, including medications, devices, and procedures, are available because people have agreed to participate in research studies.

Lists IRP clinical trials on depression recruiting adults.